Echelon Biosciences(美國(guó))

Echelon Biosciences

美國(guó)EchelonBioscienceswww.echelon-inc.comEchelon于1997年在美國(guó)猶他州成立，其前身是美國(guó)細(xì)胞信號(hào)研究中心。Echelon提供各種抗體、分析檢測(cè)試劑盒、抑制劑等產(chǎn)品，尤其擅長(zhǎng)以細(xì)胞信號(hào)、脂類(lèi)代謝和標(biāo)記物研究為主的相關(guān)產(chǎn)品。為研究治療諸如癌癥、糖尿病、炎癥、感染和心腦血管疾病專(zhuān)家提供全面有效工具。EchelonBioscienceswasformedfro maprojectundertheCenterforCellSignaling,aStateofUtahCenterofExcellence,andwasincorporatedunderthelawsofthestateofUtahasEchelonResearchLaboratories,Inc.onOctober3,1997.ThecompanyhassincechangeditsnametoEchelonBiosciencesIncorporated.Thecompanywasorganizedtofurtherthescienceoflipidcellsignalingandcriticalmetabolicenzymes,whichprovidenewandviabletargetsforthedevelopmentofpotentialdrugsanddiagnosticsforcancer,diabetes,inflammation,infections,andcardiovasculardisease.From1997through2004Echelonprimarilyusedgovernmentgrantsandproductsalesrevenuestofunditsresearchefforts.Inearly2005EchelonwaspurchasedbyAeternaZentaris(NAS:AEZS)foritsMEPantiinfe